Loading...
ProText Mobility, Inc.
TXTM•PNK
HealthcareBiotechnology
$0.001
$-0.00(-25.00%)
ProText Mobility, Inc. (TXTM) Stock Overview
Explore ProText Mobility, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for TXTMStats details for TXTM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for TXTMAnalyst Recommendations details for TXTM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc.
CEO
Mr. Roger Baylis-Duffield
Employees
1
Headquarters
258 South Military Trail, Deerfield Beach, FL
Founded
2003